Skip to main content
. 2017 Oct 27;18:501. doi: 10.1186/s13063-017-2229-4

Fig. 1.

Fig. 1

Study design of the Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM) trial